United States · 
What does Polaris Partners invest in?
Polaris Partners invests most often at Series B and Series A (55% of the rounds on record), in sectors such as Drug, Genomics and Cell Therapy.
Polaris Partners highlights
- 01
21 cheques in the last 12 months
- 02
Mostly Series B and Series A: 55% of its rounds
- 03
Sole investor in 45 rounds, median $6.4M
- 04
55 exits from the portfolio
What they do
We have collaborated with talented biotech and healthcare entrepreneurs as they build transformational companiesFrom their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- Not stated
- Stages
- Pre-seedSeedSeries ASeries BGrowthPre-IPO
- Sectors
- DrugGenomicsCell Therapy
- Based in
- Boston, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first490 appearances
- 2026
17 rounds
- Oct
- Sept
- Aug
- Jun
- Jun
- Jun
- Jun
- May
- Mar
- Mar
- Jan
- Jan
- Jan
- Jan
- Jan
- Jan
- Jan
- 2025
18 rounds
- Dec
- Nov
- Nov
- Nov
- Oct
- Oct
- Oct
- Sept
- Sept
- Aug
- Aug
- Jul
- Jun
- May
- Feb
- Jan
- Jan
- Jan
- 2024
27 rounds
- Dec
- Dec
- Nov
- Nov
- Nov
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration6 named
ACAlexandra CantleyManaging Member of the General PartneriFiling they signed
ASAmy SchulmanManaging Member of the General PartneriFiling they signed
BCBrian CheeManaging Member of the General PartneriFiling they signed
BYBryce YoungrenManaging Member of the General PartneriFiling they signed
DLDaniel LombardManaging Member of the General PartneriFiling they signed
EMEileen McGuireManaging Member of the General PartneriFiling they signed
We also hold 50 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
Exits from the portfolio
Companies it backed that were later bought or listed55 in all
BlackArrowBought by Cross MediaworksUndisclosedAug 2015
ReadyForZeroBought by AvantUndisclosedMar 2015
NextCode HealthBought by WuXi PharmaTech (Cayman)$65MJan 2015
Sun CatalytixBought by Lockheed MartinUndisclosedAug 2014
docTrackrBought by Intralinks$10MApr 2014
BalconyTVBought by The OrchardUndisclosedMar 2014
ShoeDazzleBought by JustFabUndisclosedAug 2013
Lascaux Co.Bought by EtsyUndisclosedJan 2013
FormspringBought by Spring.meUndisclosedJan 2013
BridgePoint MedicalBought by Boston ScientificUndisclosedSept 2012
Seamless ReceiptsBought by SailthruUndisclosedJun 2012
Ascend HealthBought by Universal Health ServicesUndisclosedJun 2012
EmberBought by Silicon Laboratories$72MMay 2012
The latest 20 here. An exit counts when it came after the firm's first round in the company. From historical deal records.